Watabe, Tadashi https://orcid.org/0000-0001-8658-2395
Kaneda-Nakashima, Kazuko
Shirakami, Yoshifumi
Kadonaga, Yuichiro
Ooe, Kazuhiro
Wang, Yang
Haba, Hiromitsu
Toyoshima, Atsushi
Cardinale, Jens
Giesel, Frederik L.
Tomiyama, Noriyuki
Fukase, Koichi
Funding for this research was provided by:
AMED (JP22ym0126091)
Japan Science and Technology Corporation (JPMJOP1721)
Article History
Received: 20 July 2022
Accepted: 18 October 2022
First Online: 8 November 2022
Declarations
:
: All animal experiments were performed in compliance with the guidelines of the Institute of Experimental Animal Sciences. The protocol was approved by the Animal Care and Use Committee of the Osaka University Graduate School of Medicine (approval number: 30-103-011).
: Not applicable.
: Not applicable.
: The authors declare no potential conflicts of interest relevant to this study. FLG is advisor at ABX, Telix, SOFIE Biosciences and Alpha Fusion. FLG and JC have a patent application on PSMA-1007. TW, KK, YS, YK, AT, and KF have a patent application on [<sup>211</sup>At]-labeled PSMA.